In summary, the present study provides a new molecular mechanism by which LMWF inhibits the angiogenesis, and cancer growth in bladder cancer may be associated with suppressing hypoxia-activated HIF-1 VEGF/VEGFR2-mediated signaling (Figure 5B). The gene discussed is VEGFA; the disease is urinary bladder carcinoma.